DrugDashboards

Sodium sulfate, potassium sulfate and magnesium sulfate

Sodium sulfate, potassium sulfate and magnesium sulfate · SODIUM SULFATE 17.5 g/177mL; POTASSIUM SULFATE 3.13 g/177mL; MAGNESIUM SULFATE 1.6 g/177mL · Solution · Oral · Camber Pharmaceuticals, Inc.

NDC 31722-0098-31 · 2 BOTTLE, PLASTIC in 1 CARTON / 177 mL in 1 BOTTLE, PLASTIC · ANDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. The price has fallen 50% in a year, to $0.0929 per mL — and generics that get this cheap tend to get abandoned rather than defended. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.1$0.2Jun 2025Sep 2026$0.0929
16 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$87.00
Reported to Texas DSHS · 2026 annual filing · Annora Pharma Private Ltd.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$220,713
3,440 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

25Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 3 active manufacturers+10
  • price down 50% year over year+15

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for sodium sulfate, potassium sulfate, magnesium sulfate (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA212903
TE code
AA
Approval date
Oct 18, 2024
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Sodium sulfate, potassium sulfate and magnesium sulfate (Solution)

LabelerStrengthFirst seenLast seen
Ascend Laboratories, LLCSODIUM SULFATE 17.5 g/177mL; POTASSIUM SULFATE 3.13 g/177mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 1.6 g/177mLAug 26, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.SODIUM SULFATE 17.5 g/177mL; POTASSIUM SULFATE 3.13 g/177mL; MAGNESIUM SULFATE 1.6 g/177mLAug 26, 2026Sep 2, 2026
NorthStar RxLLCSODIUM SULFATE 17.5 g/177mL; POTASSIUM SULFATE 3.13 g/177mL; MAGNESIUM SULFATE 1.6 g/177mLAug 26, 2026Sep 2, 2026
Ascend Laboratories, LLCSODIUM SULFATE 1.6 g/177mL; POTASSIUM SULFATE 3.13 g/177mL; MAGNESIUM SULFATE, UNSPECIFIED FORM 17.5 g/177mLJul 22, 2026Aug 19, 2026
Camber Pharmaceuticals, Inc.SODIUM SULFATE 1.6 g/177mL; POTASSIUM SULFATE 3.13 g/177mL; MAGNESIUM SULFATE 17.5 g/177mLJul 22, 2026Aug 19, 2026
NorthStar RxLLCSODIUM SULFATE 1.6 g/177mL; POTASSIUM SULFATE 3.13 g/177mL; MAGNESIUM SULFATE 17.5 g/177mLJul 22, 2026Aug 19, 2026
Ascend Laboratories, LLCMAGNESIUM SULFATE, UNSPECIFIED FORM 1.6 g/177mL; POTASSIUM SULFATE 3.13 g/177mL; SODIUM SULFATE 17.5 g/177mLJul 15, 2026Jul 15, 2026
Camber Pharmaceuticals, Inc.MAGNESIUM SULFATE 1.6 g/177mL; POTASSIUM SULFATE 3.13 g/177mL; SODIUM SULFATE 17.5 g/177mLJul 15, 2026Jul 15, 2026
NorthStar RxLLCMAGNESIUM SULFATE 1.6 g/177mL; POTASSIUM SULFATE 3.13 g/177mL; SODIUM SULFATE 17.5 g/177mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sodium sulfate, potassium sulfate and magnesium sulfate — NDC 31722-0098-31," retrieved September 3, 2026, https://drugdashboards.com/drug/31722009831.

Free to cite with attribution — see how the data is put together.